About this episode
Northwestern Medicine scientists are at the forefront of research investigating the most effective ways of treating obesity in children and teens and improving their access to care.
In this episode, Justin Ryder, PhD, a clinical and translational obesity scientist at Feinberg, talks about the use of new GLP-1–based medications for childhood obesity and his work on several NIH-funded projects focused on understanding how pediatric obesity impacts chronic disease risk and how biology drives weight regain.
Get every episode summarized
Each time Breakthroughs publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breakthroughs
Improving Testing and Diagnosis of Hepatitis C with Claudia Hawkins, MD, MPH
Breakthroughs
Decoding Long COVID's Impact on the Brain with Igor Koralnik, MD
Breakthroughs
Improving Imaging of the Spinal Cord with Molly Bright, DPhil
Breakthroughs
New Paths for Diagnosing and Treating Lyme Disease with Brandon Jutras, PhD
Breakthroughs